Latest developments in precancerous lesions of hepatocellular carcinoma.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 27022212)

Published in World J Gastroenterol on March 28, 2016

Authors

Zhao-Shan Niu1, Xiao-Jun Niu1, Wen-Hong Wang1, Jing Zhao1

Author Affiliations

1: Zhao-Shan Niu, Laboratory of Micromorphology, Medical College of Qingdao University, Qingdao 266071, Shandong Province, China.

Articles cited by this

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology (2009) 5.68

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun (2013) 3.06

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology (2014) 2.68

Contrast enhanced ultrasound and magnetic resonance imaging in hepatocellular carcinoma diagnosis. Med Ultrason (2013) 1.98

Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol (2010) 1.97

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut (2000) 1.84

Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med (2000) 1.71

Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma. Cancer Sci (2009) 1.64

DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med (2007) 1.59

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol (2005) 1.52

Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am J Clin Pathol (2008) 1.49

Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Am J Gastroenterol (2006) 1.48

Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol (2012) 1.46

Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol (2009) 1.36

Preneoplastic lesions in human hepatocarcinogenesis. Liver Int (2005) 1.33

Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol (2005) 1.33

Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol (2010) 1.30

Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis (2005) 1.29

DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Cancer Lett (2006) 1.27

Update on precursor and early lesions of hepatocellular carcinomas. Arch Pathol Lab Med (2011) 1.26

Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology (2012) 1.24

Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis. Eur Radiol (2011) 1.22

Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology (2007) 1.15

Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma. Int J Cancer (2009) 1.10

High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology (2001) 1.10

Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma. World J Gastroenterol (2010) 1.08

Depletion of DNMT3A suppressed cell proliferation and restored PTEN in hepatocellular carcinoma cell. J Biomed Biotechnol (2010) 1.03

Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdom Imaging (2011) 1.01

Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Liver Int (2009) 1.01

Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis (2010) 1.01

Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. Acta Histochem (2011) 1.01

Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging (2013) 1.00

Expression of DNA methyltransferases in multistep hepatocarcinogenesis. Hum Pathol (2003) 1.00

Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer (2006) 0.97

Molecular diagnosis of multistage hepatocarcinogenesis. Jpn J Clin Oncol (2010) 0.97

Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI. World J Hepatol (2014) 0.96

Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma. Hepatol Res (2010) 0.96

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging (2011) 0.96

Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis. Mod Pathol (2009) 0.93

Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging (2013) 0.93

Large liver cell change in hepatitis B virus-related liver cirrhosis. Hepatology (2009) 0.91

Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits. J Hepatol (2013) 0.91

Large liver cell dysplasia in hepatitis B virus x transgenic mouse liver and human chronic hepatitis B virus-infected liver. Intervirology (2005) 0.90

Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis. World J Gastroenterol (2014) 0.90

Frequency of TERT promoter mutations in primary tumors of the liver. Virchows Arch (2014) 0.90

Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. J Hepatol (2003) 0.89

Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations. Patholog Res Int (2011) 0.89

Liver biopsies in chronic viral hepatitis: beyond grading and staging. Arch Pathol Lab Med (2011) 0.89

Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. Eur Radiol (2015) 0.88

Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging. Liver Cancer (2012) 0.88

Liver precancerous lesions and hepatocellular carcinoma: the histology report. Dig Liver Dis (2011) 0.88

Angiogenesis in pre-malignant conditions. Br J Cancer (2008) 0.88

Cancer cell micronucleus: an update on clinical and diagnostic applications. APMIS (2012) 0.88

DNA methylation: potential biomarker in Hepatocellular Carcinoma. Biomark Res (2014) 0.86

Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer. Expert Rev Mol Diagn (2013) 0.86

Advanced precancerous lesions in the liver. Best Pract Res Clin Gastroenterol (2013) 0.86

Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma. Med Ultrason (2011) 0.85

Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes. Histopathology (2010) 0.85

RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Mol Cancer Res (2013) 0.84

Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. J Viral Hepat (2005) 0.84

Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. J Magn Reson Imaging (2013) 0.84

TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma. J Hepatol (2014) 0.83

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma. Liver Cancer (2012) 0.83

Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review). Oncol Lett (2014) 0.83

DNA ploidy and liver cell dysplasia in liver biopsies from patients with liver cirrhosis. Can J Gastroenterol (2004) 0.82

Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma. PLoS One (2014) 0.82

Roles of microRNAs in cancers and development. Methods Mol Biol (2015) 0.82

Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B. J Clin Gastroenterol (2008) 0.81

MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects. World J Gastroenterol (2014) 0.81

Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. Acta Radiol (2014) 0.81

Methylated DNA and microRNA in body fluids as biomarkers for cancer detection. Int J Mol Sci (2013) 0.81

Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations. Cancer Res (2008) 0.81

Analysis of morphological variables and arterialization in the differential diagnosis of hepatic nodules in explanted cirrhotic livers. Diagn Pathol (2007) 0.80

Large cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion. Hum Pathol (2009) 0.80

Hepatocellular dysplastic nodules. Hepatol Res (2007) 0.80

The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. J Gastroenterol (2013) 0.79

Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver. Chin J Cancer Res (2014) 0.79

The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis. Med Ultrason (2010) 0.79

Elevated Vascular Endothelial Growth Factor (VEGF) levels in the blood serum of dogs with malignant neoplasms of the oral cavity. Acta Vet Hung (2014) 0.79

Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest (2002) 0.79

Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging. Abdom Imaging (2013) 0.78

[Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma]. Zhonghua Bing Li Xue Za Zhi (2011) 0.78

The cytological characteristics of small cell change of dysplasia in small hepatic nodules. Oncol Rep (2010) 0.78

Hepatocarcinogenesis of regenerative and dysplastic nodules in Chinese patients. Hong Kong Med J (2011) 0.77

Imaging of hepatocellular carcinoma: practical guide to differential diagnosis. Clin Liver Dis (2011) 0.76

Roles of Combined Glypican-3 and Glutamine Synthetase in Differential Diagnosis of Hepatocellular Lesions. Asian Pac J Cancer Prev (2015) 0.76

Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis. Dig Liver Dis (2012) 0.76

Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma. Oncol Lett (2015) 0.76